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-Defensins are mediators of mammalian innate immunity,
and knowledge of their structure-function relationships is
essential for understanding their mechanisms of action. We
report here the NMR solution structures of the mouse Paneth
cell -defensin cryptdin-4 (Crp4) and a mutant (E15D)-Crp4
peptide, in which a conserved Glu15 residue was replaced by
Asp. Structural analysis of the two peptides confirms the
involvement of this Glu in a conserved salt bridge that is
removed in the mutant because of the shortened side chain.
Despite disruption of this structural feature, the peptide variant
retains a well defined native fold because of a rearrangement of
side chains, which result in compensating favorable interac-
tions. Furthermore, salt bridge-deficient Crp4 mutants were
tested for bactericidal effects and resistance to proteolytic deg-
radation, and all of the variants had similar bactericidal activi-
ties and stability to proteolysis. These findings support the con-
clusion that the function of the conserved salt bridge in Crp4 is
not linked to bactericidal activity or proteolytic stability of the
mature peptide.
Broad spectrum endogenous antimicrobial peptides, includ-
ing defensins, contribute to the innate immune response (1).
The mammalian defensins are all characterized by a central
-sheet that is cross-braced by an array of three disulfide bonds
but can be further divided into three classes: -, -, and -de-
fensins, based on their disulfide bond connectivities and topol-
ogy (1, 2). -Defensins are the largest at 40 amino acids and
possess a CysI-CysV, CysII-CysIV, CysIII-CysVI array (3),
whereas the -defensins comprise 32–36 amino acids and a
characteristic CysI-CysVI, CysII-CysIV, CysIII-CysV arrange-
ment of their disulfide bonds (4). The -defensins are consider-
ably smaller at only 18 residues and have a CysI-CysVI, CysII-
CysV, CysIII-CysIV framework, combined with the remarkable
feature of a head-to-tail cyclic peptide backbone, resulting from
two 9-residue gene products being joined into a circle by the
post-translational formation of two peptide bonds (5).
Mammalian-defensins were first identified inmyeloid cells
(6) but have since been found in Paneth cells of the small intes-
tine (7, 8) and in rabbit kidney (9, 10). Paneth cell -defensins,
which play an important role in entericmucosal immunity (11),
are secreted as components of granules into the lumen of small
intestinal crypts in response to cholinergic stimulation or expo-
sure to bacteria or bacterial antigens (12–14). The mouse Pan-
eth cell-defensins, termed cryptdins (Crps),5 are secreted into
the crypt lumen at concentrations of 25–100 mg/ml, orders of
magnitude above their minimal inhibitory concentrations (14).
Their antimicrobial activity is equivalent againstGram-positive
and Gram-negative bacteria, with cryptdin-4 (Crp4) displaying
the greatest mouse -defensin bactericidal activity in in vitro
assays (15). The mode of action of these peptides, which
involves nonspecific interactions and disruption of bacterial
membranes, is dependent on peptide surface positive charge
and amphipathicity, a feature common to most mammalian
-defensins.
Despite the apparent positive selection of gene duplication
and diversification evident in alignments of known -defensin
primary structures (Fig. 1), recent studies have reported on the
structural and functional roles of canonical residues conserved
in all -defensins. These include the spacing and disulfide con-
nectivities of the six Cys residues, a Gly at the position corre-
sponding to residue 19 inCrp4, and a positively charged residue
(Arg/Lys) and a negatively charged residue (Glu) found at posi-
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tions 7 and 15, respectively, in Crp4 (16–18). The disulfide
bonds maintain the -defensin fold, with mutations in either
the CysI-CysVI or CysIII-CysV disulfide pairings, resulting in a
complete disruption of the fold (16). Despite being unfolded, all
disulfide-deficient Crp4 mutants retain or exceed native Crp4
bactericidal activity but are sensitive to proteolytic degradation
bymatrixmetalloproteinase-7, the proCrp convertase (16). The
conserved Gly19 residue is positioned in a classical -bulge in
themiddle of-strand 2. The ability of Gly to adopt a/ angle
combination not normally accessible by L-amino acids, because
of its small size and less stringent conformational restrictions, is
crucial for the structure of the sheet. Mutational studies on
human neutrophil -defensin 2 (HNP2) have revealed that
although it cannot be replaced by any other L-amino acid, a
correctly folded product can be achieved by the inclusion of a
D-amino acid, for which the required backbone conformation is
energetically favorable (18). The final -defensin canonical fea-
ture is the occurrence of Arg and Glu, respectively, at positions
7 and 15 in mouse Crp4, which are predicted to form a con-
served salt bridge (17). The role of this salt bridge in HNP2 was
investigated by site-directed mutagenesis, which showed that
salt bridge disruption or removal did not diminish HNP2 anti-
bacterial activity or HNP2 precursor folding in vitro (17). How-
ever, the mutated analogues were susceptible to proteolysis by
human neutrophil elastase, again emphasizing the need for a
well defined stable fold to prevent attack from proteases (17).
Here, we have investigated the role of this canonical salt
bridge on the native structure of -defensins. To date, reported
-defensin structures include the crystal structures of HNP3
(19) and HNP2 (18) and the NMR solution structures of the
rabbit neutrophil defensins 2 (20) and 5 (21), the rabbit kidney
defensin-1 (RK-1) (22), and mouse Crp4 (23). Although HNP2,
HNP3, and RK-1 all show the presence of a salt bridge, this
structural feature was not identified in Crp4 (23). After analysis
of NMR data for both native Crp4 and analogues, we suggest
that in the published structure a small part of the sheet has been
incorrectly aligned, leading to a lack of recognition of the key
salt bridge. Here we present the corrected high resolution solu-
tion structure of Crp4 and the structure of the mutant (E15D)-
Crp4 in which the conserved salt bridge has been removed by
effectively shortening the side chain of the Glu residue but oth-
erwise making no change to the charge state of the native pep-
tide. This study improves the understanding of the structural
and functional roles of this conserved structural feature of the
-defensin family.
EXPERIMENTAL PROCEDURES
Preparation of Recombinant Crp4 Peptide Variants—Re-
combinant Crp4 peptides were expressed in Escherichia coli as
N-terminal hexahistidine-tagged fusion proteins from the
EcoRI and SalI sites of the pET28a expression vector (Novagen,
Inc., Madison, WI) as described previously (24, 25). The Crp4
coding cDNA sequences were amplified using forward primer
ATATA TGAAT TCATG GGTTT GTTAT GCTAT (ER1-
MET-C4-F) paired with reverse primer ATATA TGTCG
ACTGT TCAGC GGCGG GGGCA GCAGT ACAA
(SLPMALCRP4R) as reported previously (24). FOR PROCRP4,
forward primer pETPCr4-F (5-GCGCG AATTC ATGGA
TCCTA TCCAA AACAC A) was paired with reverse primer
SLpMALCrp4R (5-ATATA TGTCG ACTGT TCAGC
GGCGG GGGCA GCAGT ACAA), corresponding to nucleo-
tides 104–119 and 301–327 in preproCrp4 cDNA (24). In all
instances, the reactions were performed using the GeneAmp
PCR core reagents (Applied Biosystems, Foster City, CA) by
incubating the reaction mixture at 94 °C for 5 min, followed by
successive cycles at 94 °C for 30 s, 60 °C for 30 s, and 72 °C for
30 s for 30 cycles, followed by a final extension reaction at 72 °C
for 7 min.
Mutagenesis atGlu15 andArg7 Residue Positions—Mutations
were introduced into Crp4 by PCR as described previously (16)
in the order described below. In the first round of mutagenesis
the Crp4 construct in pET-28a (25) was used as template. In
PCR 1, a mutant forward primer, e.g. C4E75D for, containing
theAsp forGlumutation at Crp4 residue position 15 flanked by
three natural codons was paired with reverse primer T7 termi-
nator (Invitrogen), a downstream sequencing primer in the
pET-28a vector. In PCR 2, the mutagenizing reverse primer
C4E75D rev, the reverse complement of the mutant forward
primer, was paired with the T7 promoter forward primer, again
from the pET-28a. Mutagenizing forward and reverse primers
were: for (E15D)-Crp4, TGCAA AAGAG GAGAT CGAGT
TCGTG GG (C4E75D for) and CCCAC GAACT CGATC
TCCTC TTTTG CA (C4E75D rev); for (E15K)-Crp4, TGCAA
AAGAG GAAAG CGAGT TCGTG GG (C4 E75K for) and
CCCAC GAACT CGCTT TCCTC TTTTG CA (C4E75K rev);
for (E15L)-Crp4, TGCAA AAGAG GACTA CGAGT TCGTG
GG (C4E75L for) and CCCAC GAACT CGTAG TCCTC
TTTTG CA (C4E75L rev); and for (E15G)-Crp4, TGCAA
AAGAG GAGGA CGAGT TCGTG GG (C4E75G for) and
CCCACGAACT CGTCC TCCTC TTTTG CA (C4E75G rev).
After amplification at 94 °C for 5 min, followed by successive
cycles at 94 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s for 30
FIGURE 1. Sequence comparisons of mouse cryptdins and selected -
defensins fromvarious sources. The characteristic cysteine pattern and the
disulfide connectivities are indicated by connecting lines. Other conserved
residues, including Arg7, Glu15, and Gly19 (using the numbering of Crp4) are
shown in bold type. The sequence of the mutant studied here is given under
(E15D)-Crp4.
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cycles, followed by a final extension reaction at 72 °C for 7 min,
samples of purified products from reactions 1 and 2 were com-
bined as templates in PCR 3, using T7 promoter and terminator
primers as amplimers. Corresponding proCrp4 templates of
these variants were prepared as described (16). All of the
mutated Crp4 and proCrp4 templates were cloned in pCR-2.1
TOPO, verified by DNA sequencing, excised with SalI and
EcoRI, subcloned into pET28a plasmid DNA (Novagen), and
transformed into E. coli BL21(DE3)-CodonPlus-RIL cells
(Stratagene) for recombinant expression (24, 25).
Purification of Recombinant Crp4 Proteins—Recombinant
proteins were expressed and purified asHis-taggedCrp4 fusion
peptides (16, 24). Briefly, recombinant proteins were expressed
at 37 °C in Terrific Broth medium by induction with 0.1 mM
isopropyl-D-1-thiogalactopyranoside for 6 h at 37 °C, the cells
were lysed by sonication in 6 M guanidine-HCl in 100 mM
Tris-Cl (pH 8.1), and the soluble protein fraction was clarified
by centrifugation (24–26). His-tagged Crp4 fusion peptides
were purified using nickel-nitrilotriacetic acid (Qiagen) resin
affinity chromatography (24). After CNBr cleavage, Crp4 pep-
tides were purified by C18 reverse phase high performance liq-
uid chromatography and quantitated by bicinchoninic acid
(Pierce), and the molecular masses of purified peptides were
determined using matrix-assisted laser desorption ionization
mode mass spectrometry (Voyager-DE MALDI-TOF; PE Bio-
systems, Foster City, CA) in the Mass Spectroscopy Facility of
the Department of Chemistry at the University of California,
Irvine.
Bactericidal Peptide Assays—Recombinant peptides were
tested for microbicidal activity against E. coliML35 and Staph-
ylococcus aureus 710a (27). Bacteria (5 106 colony-forming
units/ml) resuspended in 10 mM PIPES (pH 7.4) supplemented
with 0.01 volume of trypticase soy broth were incubated with
test peptides in 50l for 1 h at 37 °C, and the surviving bacteria
were counted as colony-forming units/ml after overnight
growth on semi-solid medium (24, 25).
Exposure of Glu15 Crp4 and proCrp4 Variants toMMP-7, the
Mouse Paneth Cell Pro--defensin Convertase—Recombinant
Crp4, proCrp4, and variants with site-directed mutations at
position 15 were digested with MMP-7 and analyzed for evi-
dence of proteolysis by acid-urea PAGE (24, 28). Samples of
Crp4 variants (5 g) and proCrp4 variants (11 g) were incu-
bated with activated recombinant human MMP-7 (0.3  1.0
g) catalytic domain (Calbiochem, La Jolla, CA) in buffer con-
taining 10 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM CaCl2 for
18–24 h at 37 °C, and equimolar samples of all digests were
analyzed by acid-urea PAGE (16, 24).
NMR Spectroscopy—The samples for structure determina-
tion contained 2 mg of native Crp4 or 0.6 mg of (E15D)-
Crp4 dissolved in either 90% H2O and 10% D2O (v/v) or 100%
(v/v) D2O at pH 4.5. All of the spectral data were recorded at
600 and 500 MHz on Bruker Avance NMR spectrometers.
Two-dimensional experiments recorded included double
quantum filtered correlation spectroscopy (DQF-COSY),
TOCSY using an MLEV-17 spin lock sequence with a mixing
time of 80ms, andNOESYwithmixing times of 100, 150, or 200
ms. Selected spectral data, including preliminary data on an
additional salt bridge-deficient analogue, (R7G)-Crp4, are pre-
sented as supplementary material. The spectra were generally
acquired with 4096 complex data points in F2 and 512 incre-
ments in the F1 dimension over a spectral width of 12 ppm. The
spectra were processed on a Silicon Graphics Octane work sta-
tion using XWINNMR (Bruker). The F1 dimension was gener-
ally zero-filled to 1024 real data points, and 90° phase-shifted
sine bell window functions were applied before Fourier trans-
formation. Chemical shifts were internally referenced to 2,2-
dimethyl-2-silapentane sulfonic acid (DSS) at 0.00 ppm. Slowly
exchanging NH protons were detected by acquiring a series of
one-dimensional and TOCSY spectra of the fully protonated
peptide immediately after dissolution inD2O. Further evidence
for hydrogen bonds was deduced from amide temperature
coefficients, which were determined by recording TOCSY
spectra at 288, 293, 298, 303, and 308 K and plotting the amide
shifts as a function of temperature. The pKa of Glu15 in Crp4
and Asp15 in (E15D)-Crp4 and the C-terminal group were esti-
mated bymonitoring the effects of pH in the range of 1.1–7.5 on
the chemical shifts of resonances within the vicinity of the car-
boxylate group.
Structure Determination—Distance restraints for Crp4 were
derived primarily from 150-ms NOESY spectra recorded at
298 K and 600 MHz with additional restraints derived from a
NOESY recorded at 500 MHz with a cryogenic probe added
during refinement stage. Distance restraints for (E15D)-Crp4
were derived from a 600-MHzNOESY recorded at 298 Kwith a
mixing time of 200ms to compensate for the significantly lower
sample concentration. The spectral data were analyzed, and the
cross-peaks were assigned and integrated in CARA (29) and
converted to distance restraints using DYANA (30). Backbone
dihedral restraints were inferred from 3JHN-H coupling con-
stants derived from either the one-dimensional or a high digital
resolution double quantum filtered correlation spectroscopy.
The dihedral angle was restrained to120 30° for 3JHN-H
greater than 8 Hz (residues Cys4, Tyr5, Cys6, Arg16, Arg18,
Cys21, Leu26, Tyr27, Cys28, andCys29 for bothCrp4 and (E15D)-
Crp4. Additional  angle restraints of 100  80° were
included where the positive angle could be excluded based on
strong sequential Hi-1-HNi NOE compared with the intra
residualHi-HNiNOE. Side chain 1 angles and stereo-specific
assignments were determined on the basis of observed NOE
and 3JH-H coupling patterns (31). For a t2g3 side chain con-
formation, the 1 angles were restrained to60 30° (residues
Cys4, Tyr5, Cys11, Glu15, Phe25, Cys28, and Cys29 for Crp4 and
residues Cys4, Cys11, Asp15, Arg18, Phe25, Cys28, and Cys29 for
(E15D)-Crp4), and for a g2t3 conformation the angles were con-
strained to 180 30° (residues Val17, Ile23, and Tyr27 for Crp4
and residues Cys6, Arg13, and Tyr27 for (E15D)-Crp4). No res-
idues could be confirmed to be in the g2g3 conformation based
on experimental data. Hydrogen bonds were included into the
structure calculations for all of the amide protons concluded to
be slow exchanging or having a Tc consistent with a hydrogen
bond, only once a suitable acceptor could be identified in the
preliminary structures. In all cases these hydrogen bonds were
found between the backbone atoms within the elements of sec-
ondary structure.
Three-dimensional structures were calculated using simu-
lated annealing and energy minimization protocols from ARIA
Structures of Crp4 and (E15D)-Crp4
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(32) within the program CNS (33) as described previously (34).
The protocol involved a high temperature phase comprising
4000 steps of 0.015 ps of torsion angle dynamics, a cooling
phase with 4000 steps of 0.015 ps of torsion angle dynamics
during which the temperature is lowered to 0 K, and finally an
energy minimization phase comprising 5000 steps of Powell
minimization. The refinement in explicit water involves the
following steps: first, heating to 500 K via steps of 100 K, each
comprising 50 steps of 0.005 ps of Cartesian dynamics; second,
2500 steps of 0.005 ps of Cartesian dynamics at 500 K, before a
cooling phase where the temperature is lowered in steps of
100 K, each comprising 2500 steps of 0.005 ps of Cartesian
dynamics; finally, the structures were minimized with 2000
steps of Powell minimization.
Protein structures were analyzed using PROMOTIF and
PROCHECK and displayed using MOLMOL. Ramachandran
analysis showed that 80% of the residues are in the most
favored regions with the remaining in the additionally allowed
(20%). The coordinates representing the solution structure of
Crp4 and (E15D)-Crp4 and the experimental restraints have
been submitted to the Protein Data Bank and given the access
codes 2GW9 and 2GWP, respectively.
RESULTS
NMR Spectroscopy and Resonance Assignments of Crp4 and
(E15D)-Crp4—Sets of two-dimensional NMRdata were recorded
for both Crp4 and (E15D)-Crp4 at 600 MHz. The spectral data
were of high quality with excellent signal dispersion indicative
of a well structured peptide and no additional spin systems that
might indicate conformational heterogeneity (supplementary
material). For both peptides full assignments of both backbone
and side chain resonances were achieved using two-dimen-
sional sequential assignment strategies. The chemical shift
assignments for native Crp4 were in all cases consistent with
the assignments reported by Jing et al. (23). As expected for a
single point mutated peptide, the chemical shifts of most resi-
dues of (E15D)-Crp4 were very similar to those of the native
peptide, but some significant differences were observed in sev-
eral regions of the sequence. Most strikingly, the H side chain
proton ofArg7, which in nativeCrp4 is downfield-shifted by2
ppm (9.61 ppm), is found at 7.24 ppm in themutant, close to the
expected random coil shift of Arg residues. Other signals from
the Arg7 side chain are shifted
downfield in themutant by between
0.7 and 0.2 ppm, and a sharp reso-
nance at 6.55 ppm,which originated
from the guanidinium group of
Arg7, could not be detected in the
mutant. Additional significant dif-
ferences in the mutant chemical
shifts include the twoH protons of
Cys28, which are shifted upfield by
1.5 and 1.0 ppm, H2 of Cys11
(upfield 0.5 ppm), HN and bothHs
of Cys4 (all downfield 0.5 ppm),
and H and H2 of Tyr5 (both
downfield 0.5 ppm). Crp4 con-
tains one proline residue, Pro30,
which in both the native andmutant structures was found to be
in the trans-conformation as evident from strong Hi-1-H	i
NOEs to the preceding residue.
The presence of secondary structure in peptides can gener-
ally be readily identified by an analysis of the deviation of the
H shifts from random coil shifts (35). Fig. 2 shows the second-
ary H shifts for Crp4 and (E15D)-Crp4, from which it is clear
that the general trend is stretches of positive values, consistent
with the triple-stranded -sheet that is typical of an -defensin
fold. With the exception of Tyr5, only small differences in the
H secondary shifts are seen between the two peptides, sug-
gesting that despite the large effects on the chemical shifts of
some residues, the mutation does not significantly affect the
backbone fold.
TemperatureVariation and pHTitration Studies of Crp4 and
(E15D)-Crp4—Monitoring the amide chemical shifts of a pro-
tein as a function of temperature is a rapid and powerful
method for identifying hydrogen bond donors in a three-di-
mensional structure, because intramolecularly hydrogen-
bonded amides have a low sensitivity to temperature (36, 37).
For both Crp4 and (E15D)-Crp4 the temperature dependences
of the amide chemical shifts were determined from TOCSY
spectra over the temperature range 288–308 K. Generally
85% of amides that have a temperature coefficient (Tc) more
positive than 4.6 ppb/K are involved in intramolecular
hydrogen bonds (the probability increases to 93%, if
4.0 Tc1.0 ppb/K) (37). In Crp4 and (E15D)-Crp4 11
amides were found to have temperature coefficients  4.6
ppb/K. The data are in good agreement with amide D2O
exchange experiments, with seven of eight amides identified
as slow exchanging, having a Tc consistent with a hydrogen
bond. The exception, Arg7, has a slow exchange with the
solvent but a Tc of 5.8 ppb/K. However, Tc values are
known to be affected by strong shielding/deshielding (36)
andmay give false positives/negatives if the amide resonance
has an unusual shift. This is the case for Arg7, which at 9.88
ppm is the most downfield resonance in Crp4. For all amides
identified as hydrogen bond donors by Tc values or D2O
exchange, suitable acceptors were identified within elements
of secondary structure in the preliminary structures, with
the slow exchanging amides being part of the core of the
-sheet and the additional amides identified as hydrogen
FIGURE 2. Secondary H shifts. The difference between observed chemical shifts (ppm) and the expected
randomcoil values are shown for all residues in Crp4 and (E15D)-Crp4. Stretches of three ormore residueswith
a secondary shift0.1 ppm are characteristic of -strands.
Structures of Crp4 and (E15D)-Crp4
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bonded from Tc data being found in turns, around the edges
of the sheet, and in bulge regions.
In addition to the temperature variation experiments, both
Crp4 and (E15D)-Crp4 were subjected to pH titrations to deter-
mine the pKaofGlu/Asp15. Favorable
electrostatic interactions such as salt
bridges can have a dramatic effect on
the pKa values of the groups involved
and by monitoring the chemical shift
dependenceof resonancesadjacent to
the titrating groups the degree of sta-
bilization of the charged state from
such interactionsmay be determined.
Fig. 3 shows the chemical shift as a
function of pH for all resonances hav-
ing a significant pH dependence
(0.1 ppm) in the pH range 1.1–7.5
for Crp4 (Fig. 3A) and (E15D)-Crp4
(Fig. 3B). It is evident that the ioniza-
tion states of three groups are affected
by the pH changes within this range,
namely His10, the Arg32 C-terminal
group, and Glu/Asp15. The data were
fitted by nonlinear regression analy-
sis, which in both Crp4 and (E15D)-
Crp4 gave pKa values of 5.6 and
2.3 for His10 and the C terminus,
respectively. Strikingly, the Crp4
Glu15 and (E15D)-Crp4 Asp15 car-
boxyl groups are largely unaffected as
the pH is lowered to 3, and as a result
the full titration curves cannot be obtainedwithout subjecting the
proteins to extremeconditions.However, basedon curve fitting of
the available data for several resonances affected by protonation/
deprotonation, the 95% confidence intervals for the pKa values of
Glu/Asp in Crp4 and (E15D)-Crp4 are 1.1–1.5 and 1.0–1.7,
respectively. The expected pKa values forHis,,, and
 carboxyl
groups are6.5, 3.5–4.3, 3.9–4.0, and 4.3–4.5, respectively (38,
39); hence thenoncharged state of theHis and the charged state of
both the termini and the Glu/Asp are significantly stabilized by
interactions in the folded structure. The resonance that is most
affected by the titration of theGlu15 carboxyl group is theH pro-
ton of Arg7 in native Crp4, which at low pH start to move back
from its downfield shifted position toward its random coil value.
Structure Determination and Description of the Three-dimen-
sional Structure—From theNMRdata a set of restraints including
upper limit distance restraints based on NOE cross-peak intensi-
ties, backbone  and side chain 1 dihedral angles, and hydrogen
bond restraints was derived and used for structure determination
of the two peptides. Both structures were calculated by simulated
annealing and refined in explicit solvent and the structural and
energetic statistics for the final families of 20 structures are sum-
marized in Table 1. All of the structures are in good agreement
with the experimental data and have good covalent geometries, as
evident from lowdeviations fromoptimal bond lengths andangles
and from the Ramachandran statistics.
Fig. 4 shows a stereo view of the families of 20 structures repre-
senting the solution structures of Crp4 and (E15D)-Crp4. Both
structures, with the exception of the termini, arewell definedwith
themainelementof secondary structurebeing thecentral-sheet.
The sheet is made up by strands comprising residues 5–8, 15–21,
and 25–29, with the second strand having two bulges around res-
FIGURE 3.NMRmonitored pH titrations of Crp4 and (E15D)-Crp4. The chemical shift versus pH is plotted for all
resonances significantly affected by pH. By nonlinear regression analysis the pKa was determined to be5.6 for
His10 (affected resonances: HN 9, HN 10, HN 11, HN 12, HB1 10, and HB2 10) and2.2 for the C terminus (affected
resonances:HN32,HA32, andHB232). Finally, at lowpHseveral resonanceswereaffectedby the ionization stateof
Glu/Asp15 (HE7,HN12,HB228,HB211,HG115, andHG215 inCrp4andHN12,HB228,HB14,HN31,HN16,HB115,
andHB2 15 in (E15D)-Crp4) were identified and indicated a pKa of1.5 in both structures.
TABLE 1
NMR and refinement statistics for the families of NMR structures
Crp4 (E15D)-Crp4





Sequential (i j 1) 160 128
Medium range (i j  4) 84 38
Long range (i j 5) 198 90
Hydrogen bonds 26 (13 H-bonds) 22 (11 H-bonds)





Distance constraints (0.2 Å) 0.1/structure 0.6/structure
Maximum distance constraint
violation (Å)
0.22 Å 0.24 Å




Deviations from idealized geometry
Bond lengths (Å) 0.0041 0.0001 0.0039 0.0002
Bond angles (°) 0.56 0.037 0.56 0.027
Impropers (°) 0.44 0.032 0.43 0.033





Most favored regions 79.6 71.0
Additionally allowed 20.0 28.4
Generously allowed 0.4 0.6
a Pairwise root mean square deviation was calculated among 20 refined structures
over the structured part of the molecules, residues 4–29.
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idues 18–19 and 21–22. The conformation of these bulges
requires Gly residues at positions 19 and 21, because of the ability
of Gly to adopt backbone conformations normally not accessible
by other L-amino acids. The three strands are linked by two well
defined -turns comprising residues 12–15 and 22–25, both of
which adopt a type II conformation, and one 
-turn comprising
residues 8–10. The arrangement of the sheet and turns is sup-
ported by a large number of cross-strand NOEs, as illustrated in
Fig. 5. Also indicated in Fig. 5 is the hydrogen bond network that
was identified by analysis of amide exchange, amide proton Tc
values, and structure calculations.
Given the small size of Crp4 the structure lacks a distinct
hydrophobic core, and the main stabilizing features of the fold
are the disulfide bonds and hydrogen bonds between the polar
groups of the backbone. Some hydrophobic interactions
between side chains are present, including those involving res-
idues Cys11/Val17/Leu26/Cys28, Leu3/Tyr5/Pro30, and Cys4/
Cys6/Arg18/Cys21/Tyr27. In addition, in native Crp4 an interac-
tion between the Glu15 and Arg7
side chains can be identified. The
positioning of the two side chains,
which is confirmed by NOE pat-
terns, indicates that the Glu15 car-
boxylate group points toward the
side of the Arg side chain, coordi-
nating one of its oxygen atoms with
the H proton and the other with
one of the amino protons from the
guanidinium group. The salt bridge,
together with the Cys11-Cys28 disul-
fide bond, appears to stabilize the
residue 9–15 loop, which is the only
part of the molecule, apart from the
two termini, not involved in ele-
ments of regular secondary struc-
ture. In (E15D)-Crp4 the shortened
carboxyl-bearing side chain makes
this interaction impossible, and the
mutation results in a reorientation
of the Tyr5 side chain, which fills the
void left by the larger Glu and the
Arg7 side chains, with the latter
moving away from the molecular
core, out into solution. Electrostatic
interactions that apparently com-
pensate for the lack of the salt bridge
are formed between the Asp and the
phenolic hydrogen of Tyr5 and the
positively charged Lys12.
The Canonical Arg7–Glu15 Salt
Bridge Is Not a Determinant of Crp4
Bactericidal Activity—To investi-
gate the contribution of the Arg7–
Glu15 salt bridge to Crp4 microbici-
dal function, the bactericidal
activities of native Crp4 and Crp4
variants with salt bridge disruptions
were compared with E. coli and S.
aureus in in vitro assays (Fig. 6). Under the conditions of these
assays, the overall bactericidal activities of Crp4, (E15D)-Crp4,
(E15L)-Crp4, and (E15G)-Crp4were similar, reducing bacterial
cell survival by at least three log values at or below 10 g/ml
(Fig. 6 and data not shown). The results of additional assays
performed against strains of Vibrio cholerae, Listeria monocy-
togenes, and wild-type Salmonella enterica serovar Typhi-
murium were reproducibly similar to those in Fig. 6, as were
assays performed with a (R7G)-Crp4 variant, which also con-
tains a salt bridge disruption (data not shown). These findings
show that Crp4 bactericidal activity is independent of the
Arg7–Glu15 salt bridge, although the dose-response curves of
certain peptides differed modestly (Fig. 6). This finding is con-
sistent with the fact that corresponding salt bridge mutants
(Arg5-Glu13) of human -defensin HNP2 have bactericidal
activities equivalent to that of native HNP2 (17). Because
mutagenesis of the canonical Arg7–Glu15 salt bridge had little
or no effect onCrp4 bactericidal action, alternative roles for the
FIGURE 4. Stereo view of the structural families of Crp4 (A) and (E15D)-Crp4 (B). The structures are super-
imposed over the well defined regions (residues 4–29). Disulfide bonds are shown in gray.
Structures of Crp4 and (E15D)-Crp4
SEPTEMBER 22, 2006•VOLUME 281•NUMBER 38 JOURNAL OF BIOLOGICAL CHEMISTRY 28073









salt bridge were considered, including protection from prote-
olysis by matrix metalloproteinase-7 (MMP-7), the activating
convertase for mouse Paneth cell pro--defensins.
Disruption of the Arg7–Glu15 Salt Bridge Does Not Induce
Crp4 Susceptibility to MMP-7 Proteolysis—Mouse Paneth cell
-defensin biosynthesis requiresMMP-7-mediated proteolytic
conversion of inactive proCrps to their functionally active
forms (40, 41). Because mutations to the mouse Crp4 disulfide
array result in Crp4 proteolysis by MMP-7 (16) and because
mutations in the HNP2 salt bridge induce susceptibility to neu-
trophil elastase, the hypothesis that Arg7 or Glu15 mutants of
Crp4 and proCrp4 would be subject to MMP-7-mediated deg-
radation was tested. Native Crp4 is completely resistant to
MMP-7 in vitro, and MMP-7 activates native proCrp4 without
cleaving within the -defensin moiety of the precursor (Fig. 7
and Refs. 16, 24, 25, and 41). In contrast to the sensitivity of
Arg5/Glu13 HNP2 variants (17), none of the Crp4 or proCrp4
salt bridge variants tested, including (E15D)-Crp4, (R7G)-Crp4,
(E15G)-Crp4, (E15D)-proCrp4, (R7A)-proCrp4, and (R7G)-
proCrp4, displayed evidence of proteolysis by MMP-7 in this
highly sensitive assay (Fig. 7). These findings suggest that struc-
tural alterations induced in Crp4 by disrupting the canonical
-defensin salt bridge do not ensure sensitivity to proteolysis
per se, but that variations in peptide primary structure exclusive
of canonical positions, in particular the strong electropositive
charge of Crp4, also contribute to the proteolytic stability.
DISCUSSION
The Glu residue at position 15 is the only negatively charged
residue in Crp4 and strikingly is almost completely conserved
throughout the-defensin family. Based on structural data, this
Glu has been proposed to be involved in a conserved salt bridge
with an Arg/Lys, and in a recent study a number of mutants of
HNP2 exploring the role of this salt
bridge were generated and analyzed
with respect to bactericidal activity,
in vitro folding ability, and proteo-
lytic stability (17). Here, we have
investigated the biological and
structural consequences of remov-
ing this conserved salt bridge in a
mouse Paneth cell -defensin, Crp4.
The NMR structure of native Crp4
was recently reported, but apparent
misassignmentof a fewcrucial hydro-
gen bonds between the 2 and 3
strands resulted in a small part of one
strand being incorrectly aligned with
the sheet, and as a consequence, the
Glu15-Arg7 salt bridgewas not identi-
fied (23). However, as we show here,
the conserved salt bridge is indeed
present in the corrected structure of
Crp4, and its structural role has been
evaluated by structural analysis of the
analogue (E15D)-Crp4, in which it
has been removed.
The Structure of Crp4 and Com-
parison with Other -Defensin Structures—Themisassignment
of a few hydrogen-bonding partners in the earlier reported
Crp4 solution structure by Jing et al. (23) led to a different
arrangement of a small part of the 2 strand with respect to the
3 strand. Nevertheless the overall shape of the molecule was
very similar to that obtained in the present study. Unexpectedly
the incorrect alignment of these two  strands did not give rise
to obvious problems in the energy of the original structure.
Because the hydrogen bondswere included in all the final struc-
ture calculations the other restraints used (e.g. NOEs) did not
move the structure toward a more correct positioning of the
sheet. However, in subsequent unrestrained molecular dynam-
ics calculations, movement of the 2 strand and increased
hydrogen bonding in Crp4 was observed. Movement of 
strands is not normally observed in such unrestrained molecu-
lar dynamics simulations, indicating that part of the original
structure had considerable strain associatedwith it. During this
movement process the other two strands of the sheet remained
in their correct orientation, which is identical to that observed in
this study. After 6 ns the relaxed structure resembled the one
reported here and this remained stable during a further 14 ns of
simulation time.6 The results obtained in the unrestrained simu-
lations are clearly consistent with the outcome of the current
structural study of Crp4.
The present solution structure of Crp4 adopts a typical-de-
fensin fold that is characterized by a triple-stranded antiparallel
-sheet. Fig. 8 shows a comparison of Crp4, HNP3, and RK-1,
and it is clear that themost significant difference between Crp4
and most other -defensin is in the hairpin region. This is a
direct result of the loop between Cys21 and Cys28 comprising
6 N. Zhou and H. J. Vogel, data not shown.
FIGURE 5. Schematic illustration of the secondary structure of Crp4. Observed NOEs are shown as arrows,
with thick and thin arrows corresponding to strong-medium and weaker NOE interactions, respectively. The
broken arrows representNOE connections that are expected tobepresent but cannot be confirmedbecauseof
overlap with strong sequential/intraresidual cross-peaks. Hydrogen bonds for which donors were identified
from amide exchange and Tc values and acceptors identified by preliminary structure calculations are indi-
cated by thick broken lines. An identical network of NOEs albeit with a few of the weaker long range ones
missing because of the lower concentration used is seen in (E15D)-Crp4.
Structures of Crp4 and (E15D)-Crp4
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only six residues in Crp4 compared with nine in HNP3 and
eight in RK-1. The longer loop changes not only the structure of
the hairpin turn but also quite dramatically the direction in
which the turn projects away from the core of the molecule.
Although the number of residues in this loop in HNP3 allows
the two anti-parallel strands to be linked by a regular -turn,
the lack of three residues, an odd number, means that in Crp4 a
bulge has to be formed for the turn to be able to adopt a regular
conformation. This is facilitated byGly22, which allows a classic
-bulge to be formed. A similar conformation is seen for Gly19
in all known -defensin structures, and it has been shown to be
crucial for the structure of the sheet and thus is likely respon-
sible for the evolutionary conservation of a Gly at this position
(18). The structure of the molecular core with the central
-sheet and the disulfide bonds is highly conserved, and the
three molecules superimpose over this region with a root mean
square deviation of1.4 Å.
Salt bridges are notoriously difficult to identify by NMR
because side chain orientations are not always well defined, and
proton-proton distances across salt bridges are in most cases
too long to lead to detectable NOEs. However, the existence of
a salt bridge may be deduced by determining the pKa of the
interacting carboxylate group, which is typically lowered sev-
eral pH units relative to a free carboxylate (42). By monitoring
the chemical shifts as a function of pH, we determined that the
pKa of Glu15 in Crp4 is1.5, consistent with the presence of a
salt bridge. The structure shows that the salt bridge interacts
“side-on” with Arg7, which provides a definitive explanation for
both the unusual shift of the Arg7 H proton and the slow
exchange behavior observed for the amino protons from the gua-
nidinium group. Both protons have several NOEs to surrounding
groups, and the large chemical shift changes observed for theArg7
H proton when Glu15 is protonated support their unusually well
defined position in the structure. The pH titrations also revealed
unusually low pKa values for His10 and the C-terminal carboxyl,
Arg32. Arg32 in Crp4 is found very close to the N terminus (Gly1),
and the lowpKa is likely a reflectionof theproximityof thepositive
charges of Gly1 as well as the positive charge of its own side chain.
Similarly, His10 does not have a direct interaction with another
charged group, but the overall positive nature of Crp4 and the
presence of several close by positive charges includingArg7, Lys12,
and Arg13 are likely disfavoring the protonated form.
Structural Effects of the Glu15 to Asp15 Mutation in Crp4—
With the only exception of two sequences from guinea pig and
one from rhesus enteric defensin-6, the Arg/Lys-Glu pair of
oppositely charged residues is conserved throughoutmore than
40 known -defensins. Interestingly, no members of the family
have an Asp rather than a Glu at the corresponding position,
despite the two residues only differing in a single base pair on a
genetic level and both potentially having the ability to form salt
bridgeswith positively charged residues. This observation leads
to the question: what is the role of the salt bridge in the mam-
malian -defensins? In a recent study on HNP2, several
mutants disrupting the salt bridge were generated, and it was
found that the salt bridge is not needed for biological activity
nor in vitro folding of HNP2 precursors, although the in vitro
folding of mature domains was affected (17). In contrast, the
mutated analogues were more susceptible to degradation by
neutrophil elastase, a major protease that colocalizes with
HNP2 in neutrophil azurophilic granules, suggesting that the
salt bridge may contribute to protease resistance in vivo. Here,
despite clear structural implications of a conservative substitu-
tion at the Arg7–Glu15 salt bridge disruption to the Crp4 9–15
loop, biological and biochemical consequences of those struc-
turalmodifications were not evident from assays of bactericidal
activity and in vitroproteolytic precursor activation ofCrp4 salt
bridge variants, strongly suggesting a different primary role for
the salt bridge at least in the case of the more highly cationic
mouse Paneth cell -defensins.
FIGURE6.BactericidalactivityofCrp4Arg7–Glu15saltbridgevariants.Expo-
nentially growing E. coliML 35 (A) or S. aureus (B) were exposed to the peptide
concentrations shown50l of 10mMPIPES,pH7.4, 1%TSB (trypticase soybroth)
(v/v) for 1 h at 37 °C (“Experimental Procedures”). Following exposure, bacteria
were plated on semi-solid medium and incubated for 16 h at 37 °C. Surviving
bacteria were quantitated as colony-forming units/ml for each peptide concen-
tration. Bacterial counts below1 103 colony-forming units/ml indicate that no
surviving colonies were detected., Crp4; F, (E15D)-Crp4; , (E15L)-Crp4; ƒ,
(E15G)-Crp4.
Structures of Crp4 and (E15D)-Crp4
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As is evident from an initial analysis of the NMR data,
replacement of the conserved Glu does not affect the well
defined overall fold, which is characterized by excellent
chemical shift dispersion typical of
-sheet structures. However, al-
though the secondary shifts (Fig. 2)
are generally very similar in the two
peptides, there are some significant
differences, both locally around the
mutations and in other regions,
confirming structural changes at a
minimum associated with side
chain orientations. Fig. 9 shows
a comparison of the lowest energy
structures of native Crp4 and
(E15D)-Crp4 and illustrates the
main differences around the muta-
tion. Although the projection of the
Asp15 side chain does not differ
between the two peptides, Arg7 has
rotated, and its charged side chain
projects into the solution in the
mutant structure. However, the
most striking difference is the posi-
tion of the Tyr5 side chain, which
folds in and fills the space left by the
mutation. As a result a large number
of new NOEs are seen for the Tyr
side chain aromatic protons, and
its position explains the large chem-
ical shift differences observed in
(E15D)-Crp4. Tyr5 forms new inter-
actions with the Cys11–Cys28 disul-
fide, as well as Arg7 and Pro30 side
chains. The observation that the
Asp15 pKa in (E15D)-Crp4 is similar
to what is seen for Glu15 in native
Crp4 was initially a surprise. How-
ever, from the structure it is clear
that new interactions that stabilize
the charged state of Asp15 are
formed. The reorientation of Tyr5
allows a strong electrostatic interac-
tion between theAsp15 and the phe-
nolic hydrogen on the Tyr5 side
chain. Interactions between Asp
and hydrogen bond donors can be
highly stabilizing in protein struc-
tures (42). Furthermore, the posi-
tively charged Lys12 side chain can
interact closely with the Asp/Glu15
carboxyl. Although Lys12 is in the
proximity of the Glu/Asp15 in both
Crp4 and (E15D)-Crp4, it appears
from the structure that they interact
more closely in (E15D)-Crp4. This
observation is supported by the fact
that in (E15D)-Crp4 the Lys12 side
chain displays a chemical shift separation of both the 	 and 
methylene protons, strongly suggesting an ordered conforma-
tion. This is in contrast to what is seen in Crp4 where the Lys12
FIGURE 7.Crp4andproCrp4Arg7–Glu15 saltbridgevariantsare insensitive toMMP-7-mediatedproteolysis.
Samples of Crp4 (5 g), proCrp4 (11 g), and Crp4 and proCrp4 variants with substitutions at Arg7 or Glu15 were
incubatedovernightat37 °C in thepresenceorabsenceofMMP-7, themousepro--defensinconvertase. InA, 5-g
samples of Crp4 (lanes 1 and 2), (R7G)-Crp4 (lanes 3 and 4), and (E15G)-Crp4 (lanes 5 and 6) were incubatedwith (	)
or without () MMP-7, subjected to analytical acid-urea PAGE, and stained with Coomassie Blue (“Experimental
Procedures”). Theupperarrowdenotes thepositionof theMMP-7enzyme. InB, 5-gsamplesofCrp4 (lanes1and2)
and (E15D)-Crp4 (lanes 5 and 6) or 10-g samples of proCrp4 (lanes 3 and 4) and proCrp4 variants (E15D)-proCrp4
(lanes7and8), (R7A)-proCrp4(lanes9and10),or (R7G)-proCrp4(lanes11and12)were incubatedwithout ()orwith
(	) MMP-7, analyzed by acid-urea PAGE, and stainedwith Coomassie Blue as inA. The difference in position of the
bands containing the Crp4 analogues is a result of the electrophoretic mobility in acid-urea PAGE analysis being
affected by the number of charged residues in the peptide.
FIGURE 8. Comparison of the NMR solution structure of Crp4 (A), the crystal structure of HNP3 (19) (B)
(Protein Data Bank code 1DFN), and NMR solution structure of RK-1 (22) (C ) (Protein Data Bank code
1EWS). All of the structures are shown in ribbon style with the disulfide bonds in yellow ball-and-stick repre-
sentation, illustrating the cross-braced central -sheet. The main structural differences are in the hairpin and
are a direct result of the different lengths of the loop between CysIV and CysV (6, 8, and 9 residues in Crp4, RK-1,
and HNP3, respectively). The side chains of the conserved Arg/Lys-Glu form a tight electrostatic interaction in
all three structures. Both termini are flexible in all peptides as evident from disorder in the structural family of
Crp4 and RK-1 and from the lack of density for the terminal residues in the x-ray analysis of HNP3.
Structures of Crp4 and (E15D)-Crp4
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side chain appears to be moving freely in solution, and as a
result the geminal methylene protons have identical chemical
shifts. A hydrogen bond between the Lys12 backbone amide and
theGlu/Asp carboxyl group is present in both peptides. In addi-
tion it should be noted that both Crp4 and (E15D)-Crp4 have a
large number of positive charges, and although they are not in
direct contact with the Glu/Asp15 carboxyl, a number of them
are within the proximity and likely contribute to its very low
pKa. These include Arg7, Lys12, Arg13, Arg16, Arg18, Arg31, and
Arg32, all of which are within 8 Å of the Glu/Asp15 carboxyl in
some of the structures of the ensemble.
The observation that in HNP2 mutations disrupting the
salt bridge lead to highly increased susceptibility to proteo-
lytic degradation strongly suggests that the loop structure
has been disrupted and is likely flexible. However, no such
effect is seen in (E15D)-Crp4. Although structural flexibility
is hard to judge from the structure itself, there is no evidence
of flexibility from line broadening, lack of NOEs, or random
coil-like chemical shifts in this area, strongly suggesting that
the compensating interactions in (E15D)-Crp4 are enough
to retain the well defined stable fold.
Concluding Remarks—In summary we have reported the solu-
tion structures and biochemical properties of Crp4 and a salt
bridge-deficient (E15D)-Crp4 mutant. Despite the extensive con-
servation of this salt bridge throughout the -defensin peptide
family, our findings show that its disruption does not significantly
affect the overall fold of the peptide but does induce some local
structural changes involving side chains around the point of the
mutation.Thesechanges compensate for the lackof the salt bridge
and appear to stabilize the fold as evident from the apparent well
defined structure, as well as the low pKa of Asp15 in (E15D)-Crp4.
The NMR data are consistent with a stable structure and lacks
evidenceof dynamicprocesses suchas additional resonances from
multiple conformations and exchange broadening. Furthermore,
mutations of the salt bridge do not affect in vitro biological
activity or the proteolytic stability of Crp4, which has been
shown to be the case in HNP2 (17). Although HNP2 precur-
sors with a disrupted salt bridge can be folded in vitro (17),
perhaps the conserved salt bridge is under positive selection
in -defensins to facilitate folding or trafficking in the endo-
plasmic reticulum in vivo rather than determining the stabil-
ity or activity of the final folded product.
REFERENCES
1. Ganz, T. (2003) Nat. Rev. Immunol. 3, 710–720
2. Selsted, M. E., and Ouellette, A. J. (2005) Nat. Immunol. 6, 551–557
3. Tang, Y. Q., and Selsted, M. E. (1993) J. Biol. Chem. 268, 6649–6653
4. Selsted, M. E., and Harwig, S. S. (1989) J. Biol. Chem. 264, 4003–4007
5. Tang, Y. Q., Yuan, J., Osapay, G., Osapay, K., Tran, D., Miller, C. J.,
Ouellette, A. J., and Selsted, M. E. (1999) Science 286, 498–502
6. Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton,
D. F., and Lehrer, R. I. (1985) J. Clin. Investig. 76, 1427–1435
7. Ouellette, A. J., Miller, S. I., Henschen, A. H., and Selsted, M. E. (1992)
FEBS Lett. 304, 146–148
8. Jones, D. E., and Bevins, C. L. (1992) J. Biol. Chem. 267, 23216–23225
9. Bateman, A., MacLeod, R. J., Lembessis, P., Hu, J., Esch, F., and Solomon,
S. (1996) J. Biol. Chem. 271, 10654–10659
10. Wu, E. R., Daniel, R., and Bateman, A. (1998) Peptides 19, 793–799
11. Salzman, N. H., Chou, M. M., de Jong, H., Liu, L., Porter, E. M., and
Paterson, Y. (2003) Infect. Immun. 71, 1109–1115
12. Satoh, Y., Ishikawa, K., Ono, K., and Vollrath, L. (1986) Digestion 34,
115–121
13. Satoh, Y. (1988) Cell Tissue Res. 251, 87–93
14. Ayabe, T., Satchell, D. P., Wilson, C. L., Parks, W. C., Selsted, M. E., and
Ouellette, A. J. (2000) Nat. Immunol. 1, 113–118
15. Ouellette, A. J., Hsieh, M. M., Nosek, M. T., Cano-Gauci, D. F., Huttner,
K.M., Buick, R.N., and Selsted,M. E. (1994) Infect. Immun.62, 5040–5047
16. Maemoto, A., Qu, X., Rosengren, K. J., Tanabe, H., Henschen-Edman, A.,
Craik, D. J., and Ouellette, A. J. (2004) J. Biol. Chem. 279, 44188–44196
17. Wu, Z., Li, X., de Leeuw, E., Ericksen, B., and Lu, W. (2005) J. Biol. Chem.
280, 43039–43047
18. Xie, C., Prahl, A., Ericksen, B., Wu, Z., Zeng, P., Li, X., Lu, W. Y.,
Lubkowski, J., and Lu, W. (2005) J. Biol. Chem. 280, 32921–32929
19. Hill, C. P., Yee, J., Selsted, M. E., and Eisenberg, D. (1991) Science 251,
1481–1485
20. Pardi, A., Zhang, X. L., Selsted, M. E., Skalicky, J. J., and Yip, P. F. (1992)
Biochemistry 31, 11357–11364
21. Pardi, A., Hare, D. R., Selsted, M. E., Morrison, R. D., Bassolino, D. A., and
Bach, A. C., II (1988) J. Mol. Biol. 201, 625–636
22. McManus, A. M., Dawson, N. F., Wade, J. D., Carrington, L. E., Winzor,
D. J., and Craik, D. J. (2000) Biochemistry 39, 15757–15764
23. Jing,W., Hunter, H. N., Tanabe, H., Ouellette, A. J., and Vogel, H. J. (2004)
Biochemistry 43, 15759–15766
24. Shirafuji, Y., Tanabe, H., Satchell, D. P., Henschen-Edman, A., Wilson,
C. L., and Ouellette, A. J. (2003) J. Biol. Chem. 278, 7910–7919
25. Satchell, D. P., Sheynis, T., Shirafuji, Y., Kolusheva, S., Ouellette, A. J., and
Jelinek, R. (2003) J. Biol. Chem. 278, 13838–13846
26. Satchell, D. P., Sheynis, T., Kolusheva, S., Cummings, J., Vanderlick, T. K.,
Jelinek, R., Selsted, M. E., and Ouellette, A. J. (2003) Peptides 24,
1795–1805
27. Lehrer, R. I., Barton, A., and Ganz, T. (1988) J. Immunol. Methods 108,
153–158
28. Selsted, M. E. (1993) Genet. Eng. 15, 131–147
29. Keller, R. (2004) The Computer Aided Resonance Assignment Tutorial, 1st
Ed., Cantina Verlag, Goldau, Switzerland
30. Guntert, P., Mumenthaler, C., and Wuthrich, K. (1997) J. Mol. Biol. 273,
283–298
31. Wagner, G. (1990) Prog. NMR Spectrosc. 22, 101–139
32. Linge, J. P., and Nilges, M. (1999) J. Biomol. NMR 13, 51–59
FIGURE 9. Structural comparison of the NMR structures of native Crp4
and (E15D)-Crp4. The structures are shown in ribbon representation with
side chains of key residues around the site of the mutation in ball-and-stick.
The E15D mutation has little effect on the backbone fold but results in side
chain reorientations. Most strikingly the Tyr5 (green) side chain packs into the
space left by the Arg7 (blue) moving out into solution, and it forms electro-
static interactions with Asp15 (cyan) as well as stacking of the aromatic side
chain with groups from Arg7, Cys28 (yellow) and Pro30 (gray). The positively
charged Lys12 (red) may form electrostatic interactions with Glu15/Asp15 in
both peptides.
Structures of Crp4 and (E15D)-Crp4
SEPTEMBER 22, 2006•VOLUME 281•NUMBER 38 JOURNAL OF BIOLOGICAL CHEMISTRY 28077









33. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P.,
Grosse-Kunstleve, R.W., Jiang, J. S., Kuszewski, J., Nilges,M., Pannu,N. S.,
Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta
Crystallogr. Sect. D Biol. Crystallogr. 54, 905–921
34. Rosengren, K. J., Daly, N. L., Plan, M. R., Waine, C., and Craik, D. J. (2003)
J. Biol. Chem. 278, 8606–8616
35. Wishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S., and Sykes, B. D.
(1995) J. Biomol. NMR 5, 67–81
36. Cierpicki, T., Zhukov, I., Byrd, R. A., andOtlewski, J. (2002) J.Magn. Reson.
157, 178–180
37. Cierpicki, T., and Otlewski, J. (2001) J. Biomol. NMR 21, 249–261
38. Bundi, A., and Wuthrich, K. (1979) Biopolymers 18, 285–297
39. Matthew, J. B., Gurd, F. R., Garcia-Moreno, B., Flanagan, M. A., March,
K. L., and Shire, S. J. (1985) CRC Crit. Rev. Biochem. 18, 91–197
40. Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., Lopez-Boado, Y. S.,
Stratman, J. L., Hultgren, S. J., Matrisian, L. M., and Parks, W. C. (1999)
Science 286, 113–117
41. Ayabe, T., Satchell, D. P., Pesendorfer, P., Tanabe, H., Wilson, C.
L., Hagen, S. J., and Ouellette, A. J. (2002) J. Biol. Chem. 277,
5219–5228
42. Joshi, M. D., Hedberg, A., and McIntosh, L. P. (1997) Protein Sci. 6,
2667–2670
Structures of Crp4 and (E15D)-Crp4
28078 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 38•SEPTEMBER 22, 2006














Yoshinori Shirafuji, Xiaoqing Qu, Hans J. Vogel, Andre J. Ouellette and David J. Craik
K. Johan Rosengren, Norelle L. Daly, Liselotte M. Fornander, Linda M. H. Jönsson,
CRYPTDIN-4 AND (E15D)-CRYPTDIN-4
-Defensins: SOLUTION STRUCTURES OF MOUSEαMammalian Paneth Cell 
Structural and Functional Characterization of the Conserved Salt Bridge in
doi: 10.1074/jbc.M604992200 originally published online July 20, 2006
2006, 281:28068-28078.J. Biol. Chem. 
  
 10.1074/jbc.M604992200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  






This article cites 41 references, 16 of which can be accessed free at
 at UQ Library on October 9, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
